A separate study demonstrated that IL-2 not only facilitates the in vitro expansion of tumor-infiltrating lymphocytes (TIL) and enhances the generation of CD8-positive TIL, thereby improving their tumor recognition and attack capabilities (77). The gene discussed is IL2; the disease is neoplasm.